Camlin Fine Sciences share price
You have to be logged in to add this to Watchlist.- ₹169.80(1.56%)March 18, 2025 15:29:07 PM IST
- NSE
- BSE
- Vol : 1.49M (NSE + BSE)Last 20 day avg : 2.48 M
Camlin Fine Sciences is trading 1.56% upper at Rs 169.80 as compared to its last closing price. Camlin Fine Sciences has been trading in the price range of 172.45 & 166.30. Camlin Fine Sciences has given 30.67% in this year & -1.44% in the last 5 days. There are 2 analysts who have initiated coverage on Camlin Fine Sciences. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of -4.14 Crores in its last quarter.Listed peers of Camlin Fine Sciences include India Glycols (1.75%), Kiri Industries (5.62%), Camlin Fine Sciences (1.56%).The Mutual Fund holding in Camlin Fine Sciences was at 4.06% in 31 Jan 2025. The MF holding has increased from the last quarter. The FII holding in Camlin Fine Sciences was at 0.82% in 31 Jan 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Mar 18, 2025, 11:04 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values3.31The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility1.19Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.79The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable
The company's revenue grew in December quarter by 12.34% from Rs 433.49 crore to Rs 385.89 crore, year-on-year- The company has reduced its December quarter loss by 64.90% from Rs 11.79 crore to Rs 4.14 crore, year-on-year
- The debt to equity of the company is higher than the industry median
- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 166.10
- R2
- 189.25
- R3
- 203.15
- S1
- 129.05
- S2
- 115.15
- S3
- 92.00
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| India Glycols | Moderately Bearish | 1,114.50 | 1.75 | 3,450.66 | 19.51 | 1.62 | 0.75 | 36.33 |
| Kiri Industries | Bullish | 608.00 | 5.62 | 3,384.35 | 22.96 | 1.09 | - | 0.85 |
| Camlin Fine Sciences | Bullish | 169.80 | 1.56 | 3,195.12 | - | 3.31 | - | 40.46 |
| Tanfac Industries | Bullish | 3,266.70 | 4.24 | 3,258.53 | 58.65 | 13.36 | 0.23 | - |
| Nocil | Bearish | 179.00 | 3.56 | 2,988.59 | 24.46 | 1.72 | 1.71 | 0.64 |
- Pledged found - Promoter(s) have pledged 10.84% of shares.
- Promoter(s) have decreased pledged shares to 12.43% from 10.84% earlier.
- Promoter(s) holding is moderate at 49.10%
- Promoter(s) have increased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has increased by 0.06 percentage points from previous quarter
- Mutual Funds holding has increased by 0.68 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-14 | Quarterly Results |
| 2025-01-02 | Others |
| 2024-11-22 | Rights issue of Equity Shares |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
- IndustryChemical Manufacturing
- ISININE052I01032
- BSE Code532834
- NSE CodeCAMLINFINE
Camlin Fine Sciences is trading at 169.80 as on Tue Mar 18 2025 09:59:07. This is 1.56% upper as compared to its previous closing price of 167.20.
The market capitalization of Camlin Fine Sciences is 3195.12 Cr as on Tue Mar 18 2025 09:59:07.
The average broker rating on Camlin Fine Sciences is Buy. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Camlin Fine Sciences is 175.35 whereas the 52 wk low is 78.15
Camlin Fine Sciences can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 18.05
- Dividend Yield: 0.00%
- D/E ratio: -
Camlin Fine Sciences reported a net profit of -92.75 Cr in 2024.
The Mutual Fund Shareholding was 4.06% at the end of 31 Jan 2025.